Skip to main content »

Trinity College Dublin

|Skip Breadcrumbs|
bulletin banner|  
| Skip Primary Navigation |
 

Enterprise Ireland have awarded the 2011/2012 innovation award

Enterprise Ireland have awarded the 2011/2012 innovation award to a project on RAMAN spectroscopy in cervical cancer to a project jointly held by DIT and TCD. The DIT lead is Fiona Lyng PhD. The TCD leads are Cara Martin PhD and Professor John O'Leary. The work is being performed in the Coombe molecular biology lab.

Gordon Elliot (Tech Transfer,TCD) has been working on this for several months.

The new technique is a new diagnostic approach which can characterise the cell's DNA, RNA, protein and metabollome in one simple assay. We are now able to say whether a cell is cancerous, pre-cancerous, involved in inflammation or normal. We can now for the first time in- situ molecular type HPV in a cervical smear sample.

The technology can be applied to any pre-cancer or cancer case (and is not just limited to the cervix). It obviously has huge implications for cancer and pre-cancer detection. EI have now appointed a commercialisation partner who is discussing with TCD and DIT how to take this forward particularly in the US cancer diagnostic and theranostic arena.

Contact: Mary O'Neill | Last updated: Nov 02 2011 | Back to top
School of Medicine, Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 | Tel:+353-1-896-3121